Nothing Special   »   [go: up one dir, main page]

SE9604486D0 - Novel formulation - Google Patents

Novel formulation

Info

Publication number
SE9604486D0
SE9604486D0 SE9604486A SE9604486A SE9604486D0 SE 9604486 D0 SE9604486 D0 SE 9604486D0 SE 9604486 A SE9604486 A SE 9604486A SE 9604486 A SE9604486 A SE 9604486A SE 9604486 D0 SE9604486 D0 SE 9604486D0
Authority
SE
Sweden
Prior art keywords
novel formulation
formulation
budesonide
nose
treatment
Prior art date
Application number
SE9604486A
Other languages
English (en)
Inventor
Hans Nilsson
Gordon Santesson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9604486A priority Critical patent/SE9604486D0/sv
Publication of SE9604486D0 publication Critical patent/SE9604486D0/sv
Priority to US08/846,960 priority patent/US6291445B1/en
Priority to FR9714662A priority patent/FR2756739B1/fr
Priority to ZA9710601A priority patent/ZA9710601B/xx
Priority to ES009702483A priority patent/ES2133130B1/es
Priority to DK97948065T priority patent/DK0907365T3/da
Priority to TR1998/01501T priority patent/TR199801501T1/xx
Priority to CA002243083A priority patent/CA2243083A1/en
Priority to EP02028325A priority patent/EP1310243B1/en
Priority to HU0000575A priority patent/HUP0000575A3/hu
Priority to PT02028325T priority patent/PT1310243E/pt
Priority to NZ330925A priority patent/NZ330925A/xx
Priority to JP10525511A priority patent/JP2000508675A/ja
Priority to KR1019980706002A priority patent/KR19990082273A/ko
Priority to DK02028325T priority patent/DK1310243T3/da
Priority to DE69721766T priority patent/DE69721766T2/de
Priority to DE69738000T priority patent/DE69738000T2/de
Priority to AU54211/98A priority patent/AU726515B2/en
Priority to PCT/SE1997/001998 priority patent/WO1998024450A1/en
Priority to PT97948065T priority patent/PT907365E/pt
Priority to CNB971920796A priority patent/CN1168450C/zh
Priority to AT02028325T priority patent/ATE369118T1/de
Priority to EP97948065A priority patent/EP0907365B1/en
Priority to CZ19982437A priority patent/CZ295792B6/cs
Priority to IL12553497A priority patent/IL125534A/xx
Priority to AT97948065T priority patent/ATE239482T1/de
Priority to GR970100477A priority patent/GR1003011B/el
Priority to BE9700979A priority patent/BE1011394A5/fr
Priority to IE970854A priority patent/IE970854A1/en
Priority to NL1007706A priority patent/NL1007706C2/nl
Priority to NO983555A priority patent/NO983555L/no
Priority to HK99104513A priority patent/HK1020522A1/xx
Priority to US09/933,974 priority patent/US6686346B2/en
Priority to US10/716,357 priority patent/US6986904B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE9604486A 1996-12-05 1996-12-05 Novel formulation SE9604486D0 (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE9604486A SE9604486D0 (sv) 1996-12-05 1996-12-05 Novel formulation
US08/846,960 US6291445B1 (en) 1996-12-05 1997-04-29 Low dose budesonide formulations and uses thereof
FR9714662A FR2756739B1 (fr) 1996-12-05 1997-11-21 Nouvelle formulation de budesonide
ZA9710601A ZA9710601B (en) 1996-12-05 1997-11-25 Novel formulation
ES009702483A ES2133130B1 (es) 1996-12-05 1997-11-27 Nueva formulacion de budesonida, su uso y recipiente que la contiene.
AT97948065T ATE239482T1 (de) 1996-12-05 1997-11-28 Neue arzneiformulierung
DE69738000T DE69738000T2 (de) 1996-12-05 1997-11-28 Neue Arzneiformulierung enthaltend Budesonide
CNB971920796A CN1168450C (zh) 1996-12-05 1997-11-28 新制剂
CA002243083A CA2243083A1 (en) 1996-12-05 1997-11-28 Low dosage of budesonide
EP02028325A EP1310243B1 (en) 1996-12-05 1997-11-28 Novel formulation comprising budesonide
HU0000575A HUP0000575A3 (en) 1996-12-05 1997-11-28 Novel formulation comprising budesonid as active indegredient
PT02028325T PT1310243E (pt) 1996-12-05 1997-11-28 Nova formulação contendo budesonido
NZ330925A NZ330925A (en) 1996-12-05 1997-11-28 Composition comprising 40 micrograms or less of budesonide in a metered unit dose for treating nasal conditions
JP10525511A JP2000508675A (ja) 1996-12-05 1997-11-28 新規製剤
KR1019980706002A KR19990082273A (ko) 1996-12-05 1997-11-28 신규 제형
DK02028325T DK1310243T3 (da) 1996-12-05 1997-11-28 Hidtil ukendt formulering, som omfatter budesonid
DE69721766T DE69721766T2 (de) 1996-12-05 1997-11-28 Neue arzneiformulierung
DK97948065T DK0907365T3 (da) 1996-12-05 1997-11-28 Hidtil ukendt formulering
AU54211/98A AU726515B2 (en) 1996-12-05 1997-11-28 Novel unit dose of budesonide
PCT/SE1997/001998 WO1998024450A1 (en) 1996-12-05 1997-11-28 Novel formulation
PT97948065T PT907365E (pt) 1996-12-05 1997-11-28 Nova formulacao
TR1998/01501T TR199801501T1 (xx) 1996-12-05 1997-11-28 Yeni form�lasyon.
AT02028325T ATE369118T1 (de) 1996-12-05 1997-11-28 Neue arzneiformulierung enthaltend budesonide
EP97948065A EP0907365B1 (en) 1996-12-05 1997-11-28 Novel formulation
CZ19982437A CZ295792B6 (cs) 1996-12-05 1997-11-28 Dávkovací jednotka
IL12553497A IL125534A (en) 1996-12-05 1997-11-28 Unit dose of budesonide and use thereof for nasal administration
BE9700979A BE1011394A5 (fr) 1996-12-05 1997-12-02 Nouvelle composition.
GR970100477A GR1003011B (el) 1996-12-05 1997-12-02 Νεα συνθεση
IE970854A IE970854A1 (en) 1996-12-05 1997-12-03 Novel formulation
NL1007706A NL1007706C2 (nl) 1996-12-05 1997-12-05 Nieuwe formulering.
NO983555A NO983555L (no) 1996-12-05 1998-08-03 Ny formulering
HK99104513A HK1020522A1 (en) 1996-12-05 1999-10-13 Novel formulation
US09/933,974 US6686346B2 (en) 1996-12-05 2001-08-20 Formulation
US10/716,357 US6986904B2 (en) 1996-12-05 2003-11-17 Formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9604486A SE9604486D0 (sv) 1996-12-05 1996-12-05 Novel formulation

Publications (1)

Publication Number Publication Date
SE9604486D0 true SE9604486D0 (sv) 1996-12-05

Family

ID=20404875

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9604486A SE9604486D0 (sv) 1996-12-05 1996-12-05 Novel formulation

Country Status (8)

Country Link
US (1) US6291445B1 (sv)
EP (1) EP1310243B1 (sv)
KR (1) KR19990082273A (sv)
CA (1) CA2243083A1 (sv)
DK (1) DK1310243T3 (sv)
PT (1) PT1310243E (sv)
SE (1) SE9604486D0 (sv)
ZA (1) ZA9710601B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
JP2007501683A (ja) 2003-05-22 2007-02-01 エラン ファーマ インターナショナル リミテッド γ線照射によるナノ粒子活性物質分散体の滅菌法
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
WO2005027853A2 (en) * 2003-09-19 2005-03-31 University Of Louisville Research Foundation Inc Method for treating snoring and sleep apnea with leukotriene antagonists
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US8497258B2 (en) * 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
CA2704943A1 (en) 2007-11-13 2009-05-22 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20090123390A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20150231156A1 (en) * 2007-11-13 2015-08-20 Meritage Pharma, Inc. Corticosteroid compositions
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
WO2011041509A1 (en) 2009-10-01 2011-04-07 Eurand, Inc. Orally administered corticosteroid compositions
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
US10792253B2 (en) * 2016-08-05 2020-10-06 Shin Nippon Biomedical Laboratories, Ltd. Pharmaceutical compositions
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
CN114344264A (zh) * 2021-12-27 2022-04-15 湖南醇健制药科技有限公司 一种布地奈德鼻喷雾剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992534A (en) 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
US5509404A (en) * 1994-07-11 1996-04-23 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
AU6290396A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine

Also Published As

Publication number Publication date
EP1310243B1 (en) 2007-08-08
PT1310243E (pt) 2007-09-27
CA2243083A1 (en) 1998-06-11
EP1310243A1 (en) 2003-05-14
DK1310243T3 (da) 2007-10-22
US6291445B1 (en) 2001-09-18
KR19990082273A (ko) 1999-11-25
ZA9710601B (en) 1998-08-11

Similar Documents

Publication Publication Date Title
SE9604486D0 (sv) Novel formulation
ES2133130A1 (es) Nueva formulacion de budesonida, su uso y recipiente que la contiene.
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
SE9604786D0 (sv) New compounds
MX9605650A (es) Formulaciones de propionato de fluticasona.
EP0680749A3 (fr) Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
FI950909A (sv) Fettsyraderivat
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
EP0631772A3 (en) Agent containing retinoid.
IT9041529A0 (it) Dispositivo per la correzione chirurgica dell'ametropia
FI962685A0 (sv) Användning av 2,3-diaryl-1-benzopyranderivat för framställning av ett läkemedel för behandling och förhindring av benbrist och osteoporos
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ES2103220B1 (es) Desodorantes de los efluentes de papelera a base de ester de acido undecilenico.
DK0673646T3 (da) Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme
ZA978879B (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders.
DE69632117D1 (de) Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
LV5179A3 (lv) Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai
ITAR910009V0 (it) Manipolo per sollecitazioni elettrostatiche dell'epidermide
ITBO940520A0 (it) Apparecchiatura per il trattamento dell'aria ambiente
ATA133392A (de) Revitalisierungseinrichtung zur stärkung der körpereigenen energien
TH19526A (th) วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน
FI951762A0 (sv) Substituerade morfolinderivat och användning av dessa som terapeutiska medel
KR940012897U (ko) 선풍기의 안전망 중앙원판의 전원 인가장치